Strategies for managing antidepressant-induced sexual dysfunction: A review

Current Psychiatry Reports

Volumn 8, Issue 6, 2006, Pages 431-436

  Taylor, Matthew J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMINEPTINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GINKGO BILOBA EXTRACT; GRANISETRON; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PAROXETINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; REBOXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; YOHIMBINE;

ANORGASMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPAREUNIA; EJACULATION DISORDER; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; HUMAN; IMPOTENCE; LIBIDO DISORDER; MAJOR DEPRESSION; MONOTHERAPY; ORGASM DISORDER; PAINFUL ERECTION; PATIENT COMPLIANCE; PREMATURE EJACULATION; PSYCHOTHERAPY; RANDOMIZATION; RECURRENT DISEASE; RELAPSE; REVIEW; SEXUAL DYSFUNCTION; VAGINISM;

ANTIDEPRESSIVE AGENTS; BUPROPION; BUSPIRONE; DEPRESSIVE DISORDER; FEMALE; GINKGO BILOBA; GRANISETRON; HUMANS; IMPOTENCE; MALE; RANDOMIZED CONTROLLED TRIALS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 33845898753     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-006-0047-6     Document Type: Review

References (34)

1. Rudkin L, Taylor MJ, Hawton K: Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 2004, 4:CD003382.
2. Angst J: Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998, 13(Supp16):S1-S4.
3. Montgomery SA, Baldwin DS, Riley A: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002, 69:119-140.
4. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001, 62(Suppl 3):10-21.
5. Clayton AH, Pradko JF, Croft HA, et al.: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002, 63:357-366.
6. Williams VS, Baldwin DS, Hogue SL, et al.: Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 2006, 67:204-210.
7. Croft H, Settle E, Jr, Houser T, et al.: A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999, 21:643-658.
8. Coleman CC, Cunningham LA, Foster VJ, et al.: Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999, 11:205-215.
9. Coleman CC, King BR, Bolden-Watson C, et al.: A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001, 23:1040-1058.
10. Clayton AH, Croft HA, Horrigan JP, et al.: Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006, 67:736-746.
11. Kennedy SH, Fulton KA, Bagby RM, et al.: Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 2006, 51:234-242.
12. Clayton AH, Zajecka J, Ferguson JM, et al.: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003, 18:151-156.
13. Baldwin D, Bridgman K, Buis C: Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 2006, 20:91-96.
14. Langworth S, Bodlund O, Agren H: Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. J Clin Psychopharmacol 2006, 26:121-127.
15. Delgado PL, Brannan SK, Mallinckrodt CH, et al.: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005, 66:686-692.
16. Ferguson JM, Shrivastava RK, Stahl SM, et al.: Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 2001, 62:24-29.
17. Nurnberg HG, Gelenberg A, Hargreave TB, et al.: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001, 158:1926-1928.
18. Ginsberg DL, Adler L, McCullough A, et al.: Sildenafil treatment of serotonin-reuptake inhibitor (SRI)-induced sexual dysfunction. Paper presented at 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting. Phoenix, AZ; May 28-31, 2001.
19. Nurnberg HG, Hensley PL, Gelenberg AJ, et al.: Treatment of antidepressant-associated sexual dysfunction with sildenafil. JAMA 2003, 289:56-64.
20. Fava M, Nurnberg HG, Seidman SN, et al.: Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006, 67:240-246.
21. Segraves RT, Stevenson RW, Lee J, et al.: Tadalafil treatment of erectile dysfunction in men on antidepressants. Paper presented at 157th Annual Meeting of the American Psychiatric Association. New York; May 1-6, 2004.
22. Clayton AH, Warnock JK, Kornstein SG, et al.: A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62-67.
23. Masand PS, Ashton AK, Gupta S, Frank B: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001, 158:805-807.
24. Debattista C, Solvason B, Poirier J, et al.: A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 2005, 66:844-848.
25. Landen M, Eriksson E, Agren H, Fahlen T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999, 19:268-271.
26. Michelson D, Bancroft J, Targum S, et al.: Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000, 157:239-243.
27. Kang BJ, Lee SJ, Kim MD, Cho MJ: A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2002, 17:279-284.
28. Wheatley D: Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004, 19:545-548.
29. Jespersen S, Berk M, Van Wyk C, et al.: A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin Psychopharmacol 2004, 19:161-164.
30. Nelson EB, Shah VN, Welge JA, Keck PE: A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction. J Clin Psychiatry 2001, 62:469-473.
31. Michelson D, Kociban K, Tamura R, Morrison MF: Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002, 36:147-152.
32. Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998, 159:433-436.
33. Meston CM: A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther 2004, 30:57-68.
34. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995, 152:1514-1516.